Search - tctmd.com

Displaying 181 - 200 of 2612

Sort: Relevancy | Date

News Daily News

AUGUSTUS Analysis Clarifies Antithrombotic Choice for ACS in AF Patients

Michael O'Riordan

August 26, 2024

News Daily News

Scientific Statement Reviews Current Antithrombotic Options in PAD

L.A. McKeown

August 26, 2024

News Daily News

FDA Approves Dropping Aspirin for HeartMate 3 LVAD Patients

L.A. McKeown

August 21, 2024

News Daily News

New Data Reassure on Rivaroxaban’s Role in Frail PAD Patients

L.A. McKeown

August 19, 2024

News Daily News

ACE-PROTAVI Data Solidify Protamine’s Role in Aortic Interventions

Caitlin E. Cox

August 16, 2024

News Daily News

DES Best for In-Stent Restenosis, but DCBs Also Viable

Michael O'Riordan

August 13, 2024

News Features

Initial US Commercial TriClip Cases Offer Hope, but Reimbursement Still a Big Question

L.A. McKeown

August 09, 2024

News Opinion CV Team Dispatch

August 2024 Dispatch for the CV Team

L.A. McKeown

August 01, 2024

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for July 2024

Shelley Wood

July 31, 2024

News Daily News

Registry Data Reassure on Safety With Next-Generation Watchman Device

L.A. McKeown

July 30, 2024

News Daily News

For Pragmatic RCTs, Patient-Reported ‘Hard’ Events Fall Short

L.A. McKeown

July 25, 2024

News Daily News

PCI Complications Portend Dire Outcomes: Tracking Could Be Key

Caitlin E. Cox

July 25, 2024

News Daily News

Lower-Dose Edoxaban May Be an Option After Age 80: ENGAGE AF-TIMI 48 Analysis

Todd Neale

July 12, 2024

News Daily News

Ideal Aspirin Dose in Secondary Prevention Doesn’t Differ Much by Sex

Caitlin E. Cox

July 11, 2024

News Daily News

Apixaban May Have Advantages in Patients With Liver Cirrhosis and AF

Michael O'Riordan

July 09, 2024

News Daily News

Genetic Tests for Predicting Clopidogrel Response Gain Traction: AHA

Caitlin E. Cox

June 25, 2024

News Daily News

Aspirin for Primary Prevention of CVD Remains Common in US

Todd Neale

June 24, 2024

News Daily News

Knowns and Unknowns in Subclinical Aortic Valve Thrombosis

Caitlin E. Cox

June 21, 2024

News Daily News

P2Y12 Inhibitor Pretreatment Worth Considering in STEMI When PCI Is Delayed

Yael L. Maxwell

June 20, 2024

News Daily News

RAISE: Reteplase May Be Another Option for Stroke Thrombolysis

Todd Neale

June 20, 2024

Advertisement

AUGUSTUS Analysis Clarifies Antithrombotic Choice for ACS in AF Patients

Scientific Statement Reviews Current Antithrombotic Options in PAD

FDA Approves Dropping Aspirin for HeartMate 3 LVAD Patients

New Data Reassure on Rivaroxaban’s Role in Frail PAD Patients

ACE-PROTAVI Data Solidify Protamine’s Role in Aortic Interventions

DES Best for In-Stent Restenosis, but DCBs Also Viable

Initial US Commercial TriClip Cases Offer Hope, but Reimbursement Still a Big Question

August 2024 Dispatch for the CV Team

TCTMD’s Top 10 Most Popular Stories for July 2024

Registry Data Reassure on Safety With Next-Generation Watchman Device

For Pragmatic RCTs, Patient-Reported ‘Hard’ Events Fall Short

PCI Complications Portend Dire Outcomes: Tracking Could Be Key

Lower-Dose Edoxaban May Be an Option After Age 80: ENGAGE AF-TIMI 48 Analysis

Ideal Aspirin Dose in Secondary Prevention Doesn’t Differ Much by Sex

Apixaban May Have Advantages in Patients With Liver Cirrhosis and AF

Genetic Tests for Predicting Clopidogrel Response Gain Traction: AHA

Aspirin for Primary Prevention of CVD Remains Common in US

Knowns and Unknowns in Subclinical Aortic Valve Thrombosis

P2Y12 Inhibitor Pretreatment Worth Considering in STEMI When PCI Is Delayed

RAISE: Reteplase May Be Another Option for Stroke Thrombolysis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content